{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NAGE"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":14.41,"timestamp":1751313600000,"preClose":14.22,"halted":0,"volume":1249261,"delay":0,"floatShares":51581706,"shares":78936662,"eps":0.178968,"marketStatus":"Pre-Mkt","change":0.19,"latestTime":"07-01 05:06:01 EDT","open":14.28,"high":14.69,"low":13.95,"amount":17897538.965761002,"amplitude":0.052039,"askPrice":14.41,"askSize":1,"bidPrice":13,"bidSize":300,"shortable":3,"etf":0,"ttmEps":0.178968,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1751376600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":14.41,"postHourTrading":{"tag":"盘后","latestPrice":14.28,"preClose":14.41,"latestTime":"19:42 EDT","volume":30440,"amount":438362.809,"timestamp":1751326959713},"volumeRatio":1.106352359542546,"impliedVol":0.6716,"impliedVolPercentile":0.3803},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","floatShares":51581706,"roa":"12.21%","roe":"33.47%","lyrEps":0.112605,"volumeRatio":1.106352359542546,"shares":78936662,"dividePrice":0,"high":14.69,"amplitude":0.052039,"preClose":14.22,"low":13.95,"week52Low":2.405,"pbRate":"20.55","psRate":"10.54","week52High":14.69,"institutionHeld":0,"latestPrice":14.41,"committee":0.993355,"eps":0.178968,"divideRate":0,"volume":1249261,"delay":0,"ttmEps":0.178968,"open":14.28,"prevYearClose":5.305,"prevWeekClose":14.22,"prevMonthClose":14.41,"prevQuarterClose":14.41,"fiveDayClose":13.64,"twentyDayClose":10.82,"sixtyDayClose":7.08},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NAGE\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAGE\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546729153","title":"Niagen Bioscience Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729153","media":"Reuters","labels":["executive","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546729153?lang=en_us&edition=fundamental","pubTime":"2025-06-28 04:04","pubTimestamp":1751054667,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc. held its Annual Meeting of Stockholders on June 24, 2025. During the meeting, several proposals were presented and approved. The amendment to the 2017 Equity Incentive Plan, which increases the number of shares available for issuance by 4.75 million shares of common stock, was approved. The Employee Stock Purchase Plan, allowing officers and employees to purchase shares at a discount, was also approved. Additionally, the election of directors was confirmed, with all nominated directors elected to serve.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Niagen Bioscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nNDL3vKCkD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4121"],"gpt_icon":0},{"id":"2544122704","title":"Niagen Bioscience Inc. to Participate at Roth 15th Annual London Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2544122704","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544122704?lang=en_us&edition=fundamental","pubTime":"2025-06-20 20:32","pubTimestamp":1750422731,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc. , a leading authority on NAD+ and healthy aging science, will participate in the Roth 15th Annual London Conference from June 24-26, 2025. The event will take place at the Four Seasons Hotel London at Park Lane, where Niagen Bioscience CFO, Ozan Pamir, will engage in in-person one-on-one meetings with institutional investors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Niagen Bioscience Inc. published the original content used to generate this news brief via Business Wire  on June 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDLcfq5Kc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4121"],"gpt_icon":0},{"id":"2542849655","title":"Niagen Bioscience Inc. to Participate in Prestigious BIO International Convention in Boston","url":"https://stock-news.laohu8.com/highlight/detail?id=2542849655","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542849655?lang=en_us&edition=fundamental","pubTime":"2025-06-11 20:31","pubTimestamp":1749645080,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc. will participate in the BIO 2025 International Convention, scheduled for June 16-19, 2025, in Boston, Massachusetts. The company, a global authority on NAD+ with a focus on healthy aging, will be seeking to initiate discussions with prospective partners to support the development and monetization of its emerging drug product candidates, focusing on neurodegenerative diseases such as Parkinson's disease and Ataxia Telangiectasia.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Niagen Bioscience Inc. published the original content used to generate this news brief via Business Wire  on June 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL8DGDQd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4121"],"gpt_icon":0},{"id":"2542314918","title":"Niagen Bioscience Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2542314918","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542314918?lang=en_us&edition=fundamental","pubTime":"2025-06-10 20:28","pubTimestamp":1749558480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAGE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 10, 2025 08:28 ET (12:28 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE"],"gpt_icon":0}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"NAGE","fiscalQuarterEnding":"2025/03","expectedEps":0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":0.04},{"market":"US","date":"2025-03-04","symbol":"NAGE","fiscalQuarterEnding":"2024/12","expectedEps":0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"post","actualEps":0.03},{"market":"US","date":"2024-10-31","symbol":"NAGE","fiscalQuarterEnding":"2024/09","expectedEps":0.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"post","actualEps":0.02},{"market":"US","date":"2024-08-07","symbol":"NAGE","fiscalQuarterEnding":"2024/06","expectedEps":-0.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2024-05-08","symbol":"NAGE","fiscalQuarterEnding":"2024/03","expectedEps":-0.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1748577600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAGE","date":"2025-06-27","current":77.341699,"percent":0.882353,"low":49.393282,"twenty":56.791865,"median":65.523561,"eighty":75.181504,"high":80.324484,"avg":65.429295,"sd":8.662076,"marketCap":1090904668},"quantilePoints":[{"date":"2025-03-21","current":69.624479,"twenty":69.806742,"median":70.080136,"eighty":70.353531,"marketCap":595289295},{"date":"2025-03-28","current":67.346191,"twenty":68.676711,"median":69.624479,"eighty":70.371757,"marketCap":575809933},{"date":"2025-04-04","current":60.420196,"twenty":62.662031,"median":67.938546,"eighty":69.697384,"marketCap":516592673},{"date":"2025-04-11","current":51.67157,"twenty":54.861173,"median":62.880747,"eighty":69.551574,"marketCap":441791924},{"date":"2025-04-17","current":59.600012,"twenty":54.815607,"median":61.696037,"eighty":69.259953,"marketCap":509580103},{"date":"2025-04-25","current":67.255059,"twenty":55.043436,"median":62.151694,"eighty":68.530901,"marketCap":575030758},{"date":"2025-05-02","current":68.895427,"twenty":55.954751,"median":62.880747,"eighty":69.442216,"marketCap":589055899},{"date":"2025-05-09","current":51.710369,"twenty":55.954751,"median":65.022337,"eighty":70.535794,"marketCap":729374756},{"date":"2025-05-16","current":58.761783,"twenty":54.815607,"median":62.789615,"eighty":69.71561,"marketCap":828834951},{"date":"2025-05-23","current":56.859021,"twenty":55.043436,"median":61.650471,"eighty":69.624479,"marketCap":801996485},{"date":"2025-05-30","current":60.552618,"twenty":55.242319,"median":61.364091,"eighty":69.478669,"marketCap":854094682},{"date":"2025-06-06","current":64.414107,"twenty":55.822209,"median":61.604905,"eighty":69.296406,"marketCap":908560979},{"date":"2025-06-13","current":79.132535,"twenty":56.409541,"median":62.698483,"eighty":70.55402,"marketCap":1116164400},{"date":"2025-06-20","current":77.117845,"twenty":56.623974,"median":63.647427,"eighty":71.912091,"marketCap":1087747202},{"date":"2025-06-27","current":77.341699,"twenty":56.791865,"median":65.523561,"eighty":75.181504,"marketCap":1090904668}],"updateTime":1751344990499}}}